April 6, 2026April 6, 2026 The index fell around 1% to 13,790 in intraday trade, weighed down by tariff concerns after the US revealed plans for up to 100% duties on patented pharmaceutical products. PPL Pharma, IPCA Labs, Syngene International, Divis Labs, and Max Healthcare…
April 3, 2026April 3, 2026 The Trump administration has proposed a broad tariff structure that targets copyrighted pharmaceutical products while providing short-term assistance to generic drugmakers. A 100% tariff on patented pharmaceutical items has been suggested, with implementation timetables of 120 days for large corporations and 180 days for…
April 3, 2026April 3, 2026 Indian pharma stocks fell sharply on 2 April after reports emerged that President Donald Trump may impose 100% tariffs on branded pharmaceutical imports. Companies without US pricing deals or domestic manufacturing commitments are most at risk. Markets stay shut on…
September 26, 2025September 26, 2025 Shares of Carysil Ltd, a manufacturer and exporter of home furnishings such as kitchen sinks and appliances, crashed 9% on 26 September after the US President imposed a 50% tariff. In addition to the 100% tax on branded and patented medications, the Trump administration…
The Indian market closed lower on Wednesday, as a pullback in financial stocks from near-record highs outweighed optimism fueled by U.S. President Donald Trump’s remarks hinting at a potential trade deal between the U.S. and India. The BSE Sensex declined 287.60 points, or 0.34%, to close at 83,409.69, while the NSE Nifty shed 88.40 points,…
“Our user base leaned toward opportunistic behaviour,” NRDX’s Chief Revenue Officer, Nicolas Morphitis, told Financemagnates.com in an interview discussing trader activity on the platform following US President Donald Trump’s tariff announcement. “Rather than retreating, over 60% of active clients opened new positions, particularly shorting affected indices and commodities.” Nicolas Morphitis, Chief Revenue Officer at NDRX…